http://www.exelixis.com
Exelixis, Inc. Company Intro
We drive to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future. Cancer is our cause.
Industry
Healthcare
Exelixis, Inc. Headquaters
1851 Harbor Bay Parkway
Alameda,94502
United States
Exelixis, Inc. Share price
22 Oct 2020 01:36 GMT
$22.38
0.11 (0.49 %)
Exelixis, Inc. Market cap
$6.733 B
WMC RANKING
2020
Exelixis, Inc. # 11
BiotechnologyLatest Exelixis, Inc. News
21 Oct 2020
How Fast Can Exelixis Inc. (EXEL) and Molson Coors Beverage Company (TAP) Run In The Time Of The Virus
In another most recent transaction, which held on 9/30/2020, TENAX CAPITAL LTD. bought approximately 121.2 thousand shares of Exelixis Inc. In a separate ...
21 Oct 2020
Oct 21, 2020 - Cambiar Investors Llc Buys Total SE, Uber Technologies Inc, Sysco Corp, Sells Nutrien, Pfizer Inc, Gilead Sciences Inc
The stock is now traded at around $128.22. The impact to a portfolio due to this purchase was 0.34%. The holding were 264,426 shares as of . Added: Exelixis Inc ( ...
22 Oct 2020
Follicular Thyroid Cancer Drug Market Size, Share, Scope ...
Exelixis; Inc. GlaxoSmithKline plc; Novartis AG; Pfizer Inc. The final report will add the analysis of the impact of Covid-19 in ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Exelixis, Inc. | 17.48 | 8.15 | 5.33 | 0 | 0 | 0 | 10.08 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 19 | 0 | 0 | 98.79 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 100 | 0 | 0 | 90.93 |
Exelixis, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Exelixis, Inc. | $967,775 | $565,208 | $321,012 | $6.733B | 11 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |